Muhammet Salih Ateş
Muhammet Salih Ateş publishes mostly in Cardiology and Cardiovascular Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Inflammatory Biomarkers in Disease Prognosis, Blood Pressure and Hypertension Studies and Cardiovascular Health and Disease Prevention.
- World rank
- #2,863,832 of 7,710,434 ranked researchers
- Rank in Türkiye
- #16,945 of 117,622
- Works
- 38
- Citations
- 59
- Citations per work
- 1.6
What does Muhammet Salih Ateş research?
Muhammet Salih Ateş's work is mostly in Medicine (69%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2668.6%
- Medicine2668.6%
- Everything else1231.4%
- 1Cardiology and Cardiovascular Medicine36% of their works
- 2Oncology10% of their works
- 3Radiology, Nuclear Medicine and Imaging6% of their works
- 4Surgery6% of their works
- 5Epidemiology6% of their works
- 6Pulmonary and Respiratory Medicine4% of their works
Research topics
- Inflammatory Biomarkers in Disease Prognosis
- Blood Pressure and Hypertension Studies
- Cardiovascular Health and Disease Prevention
- Cardiac Imaging and Diagnostics
- Cardiac electrophysiology and arrhythmias
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Cardiovascular Disease and Adiposity
Which keywords describe Muhammet Salih Ateş's research?
The keywords of their largest research topics: Inflammation, Cardiovascular Disease, Cardiovascular Events, Hypertension, Cancer, Immunity, Myocardial Infarction and Coronary Artery Disease.
- Perivascular Adipose Tissue
- Statins
- Long-QT Syndrome
- Arrhythmias
- Myocardial Perfusion
- Cardiac Imaging
- Arterial Stiffness
- Coronary Artery Disease
- Immunity
- Hypertension
- Cardiovascular Disease
- Inflammation
- Cardiovascular Events
- Cancer
- Myocardial Infarction
- Antihypertensive Drugs
- Blood Pressure
- Endothelial Dysfunction
- Acute Coronary Syndromes
- Cholesterol-lowering
- ST-Segment Elevation
- Epicardial Fat
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Inflammation142 topics
- Cardiovascular Disease133 topics
- Cardiovascular Events122 topics
- Hypertension122 topics
- Cancer111 topic
- Immunity111 topic
- Myocardial Infarction102 topics
- Coronary Artery Disease92 topics
- Antihypertensive Drugs61 topic
- Arterial Stiffness61 topic
- Blood Pressure61 topic
- Cardiac Imaging61 topic
- Endothelial Dysfunction61 topic
- Myocardial Perfusion61 topic
- Acute Coronary Syndromes41 topic
- Arrhythmias41 topic
- Cholesterol-lowering41 topic
- Long-QT Syndrome41 topic
- ST-Segment Elevation41 topic
- Statins41 topic
- Epicardial Fat31 topic
- Perivascular Adipose Tissue31 topic
Where does Muhammet Salih Ateş work?
Muhammet Salih Ateş's main affiliation in the publication record is Ahi Evran University, Türkiye.
How many publications and citations does Muhammet Salih Ateş have?
OpenAlex counts 38 works and 59 citations for Muhammet Salih Ateş, an h-index of 4, ranking #2,863,832 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Muhammet Salih Ateş. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.